Related Articles
SCARFF-BLOOM-RICHARDSON HISTOPROGNOSTIC GRADING CORRELATES WITH THE IMMUNOHISTOCHEMICAL EXPRESSIONS OF GENOMIC ALTERATIONS IN INFILTRATING DUCTAL CARCINOMAS (NOS) OF THE BREAST
Estrogen receptor and progesterone receptor are prognostic factors in soft tissue sarcomas
Immunohistochemical double staining with estrogen receptor and HER2 on primary breast cancer
Receptor status variation in primary breast cancer and subsequent accessible relapse
Prognostic value of estrogen receptor status can be improved by combined evaluation of p53, Bcl2 and PgR expression: an immunohistochemical study on breast carcinoma with long-term follow-up.